Skip to Content

LCE 150 (Carbidopa, entacapone and levodopa 37.5 mg / 200 mg / 150 mg)

This pill with imprint "LCE 150" is Brown, Elliptical / Oval and has been identified as Carbidopa, entacapone and levodopa 37.5 mg / 200 mg / 150 mg. It is supplied by Sandoz Inc.

Carbidopa/entacapone/levodopa is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/entacapone/levodopa 37.5 mg / 200 mg / 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for LCE 150

Carbidopa, entacapone and levodopa

Imprint:
LCE 150
Strength:
37.5 mg / 200 mg / 150 mg
Color:
Brown
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Inc
National Drug Code (NDC):
00781-5654

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide